These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12470260)

  • 1. Utility of NMR in lead optimization: fragment-based approaches.
    Huth JR; Sun C
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):631-43. PubMed ID: 12470260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of NMR screening in drug discovery.
    Fejzo J; Lepre C; Xie X
    Curr Top Med Chem; 2003; 3(1):81-97. PubMed ID: 12570779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ID NMR Methods in ligand-receptor interactions.
    Zartler ER; Yan J; Mo H; Kline AD; Shapiro MJ
    Curr Top Med Chem; 2003; 3(1):25-37. PubMed ID: 12577989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR and in silico screening.
    Rüdisser S; Jahnke W
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):591-603. PubMed ID: 12470256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-site NMR screening and linker design.
    Jahnke W; Flörsheimer A; Blommers MJ; Paris CG; Heim J; Nalin CM; Perez LB
    Curr Top Med Chem; 2003; 3(1):69-80. PubMed ID: 12570778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of NMR and high-throughput screening.
    Hajduk PJ; Burns DJ
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):613-21. PubMed ID: 12470258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR-based techniques in the hit identification and optimisation processes.
    Pellecchia M; Becattini B; Crowell KJ; Fattorusso R; Forino M; Fragai M; Jung D; Mustelin T; Tautz L
    Expert Opin Ther Targets; 2004 Dec; 8(6):597-611. PubMed ID: 15584865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective progression of nuclear magnetic resonance-detected fragment hits.
    Eaton HL; Wyss DF
    Methods Enzymol; 2011; 493():447-68. PubMed ID: 21371601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR screening in fragment-based drug design: a practical guide.
    Kim HY; Wyss DF
    Methods Mol Biol; 2015; 1263():197-208. PubMed ID: 25618347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of NMR to structure-based drug design in structural genomics.
    Powers R
    J Struct Funct Genomics; 2002; 2(2):113-23. PubMed ID: 12836668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fragment-based screening: a promising avenue for drug design].
    Krimm I
    Med Sci (Paris); 2015 Feb; 31(2):197-202. PubMed ID: 25744267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR-based screening: a powerful tool in fragment-based drug discovery.
    Klages J; Coles M; Kessler H
    Analyst; 2007 Jul; 132(7):693-705. PubMed ID: 17657909
    [No Abstract]   [Full Text] [Related]  

  • 14. Nuclear magnetic resonance-based approaches for lead generation in drug discovery.
    Peng JW; Lepre CA; Fejzo J; Abdul-Manan N; Moore JM
    Methods Enzymol; 2001; 338():202-30. PubMed ID: 11460549
    [No Abstract]   [Full Text] [Related]  

  • 15. Automation of biomolecular NMR screening.
    Ross A; Senn H
    Curr Top Med Chem; 2003; 3(1):55-67. PubMed ID: 12570777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical aspects of NMR-based fragment screening.
    Lepre CA
    Methods Enzymol; 2011; 493():219-39. PubMed ID: 21371593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR spectroscopy: the swiss army knife of drug discovery.
    Horst R; Farley KA; Kormos BL; Withka JM
    J Biomol NMR; 2020 Nov; 74(10-11):509-519. PubMed ID: 32617727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR-based methods and strategies for drug discovery.
    Salvatella X; Giralt E
    Chem Soc Rev; 2003 Nov; 32(6):365-72. PubMed ID: 14671791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of SHAPES screening in drug discovery.
    Lepre CA; Peng J; Fejzo J; Abdul-Manan N; Pocas J; Jacobs M; Xie X; Moore JM
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):583-90. PubMed ID: 12470255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug design.
    Fjellström O; Akkaya S; Beisel HG; Eriksson PO; Erixon K; Gustafsson D; Jurva U; Kang D; Karis D; Knecht W; Nerme V; Nilsson I; Olsson T; Redzic A; Roth R; Sandmark J; Tigerström A; Öster L
    PLoS One; 2015; 10(1):e0113705. PubMed ID: 25629509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.